Lucid Diagnostics Inc.

LUCD Medical devices

Develops DNA tests for esophageal cancer in patients with chronic heartburn.

Dec 2025Revenue $4.71M/yrExpenses $54.3M/yr
Figures by year

When will Lucid Diagnostics be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $4.71M and expenses $54.3M.

Fiscal year toRevenueExpensesOperating profit
Dec 2025$4.71M$54.3M−$49.6M
Dec 2024$4.35M$50.4M−$46.1M
Dec 2023$2.43M$50.9M−$48.5M
Dec 2022$377K$56.6M−$56.3M
Dec 2021$500K$27.9M−$27.4M